The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018

Abstract Background The Stress hyperglycemia ratio (SHR) is a novel marker reflecting the true acute hyperglycemia status and is associated with clinical adverse events. The relationship between SHR and mortality in patients with diabetes or prediabetes is still unclear. This study aimed to investig...

Full description

Bibliographic Details
Main Authors: Lei Ding, Hongda Zhang, Cong Dai, Aikai Zhang, Fengyuan Yu, Lijie Mi, Yingjie Qi, Min Tang
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Cardiovascular Diabetology
Subjects:
Online Access:https://doi.org/10.1186/s12933-024-02172-8
_version_ 1797275974415417344
author Lei Ding
Hongda Zhang
Cong Dai
Aikai Zhang
Fengyuan Yu
Lijie Mi
Yingjie Qi
Min Tang
author_facet Lei Ding
Hongda Zhang
Cong Dai
Aikai Zhang
Fengyuan Yu
Lijie Mi
Yingjie Qi
Min Tang
author_sort Lei Ding
collection DOAJ
description Abstract Background The Stress hyperglycemia ratio (SHR) is a novel marker reflecting the true acute hyperglycemia status and is associated with clinical adverse events. The relationship between SHR and mortality in patients with diabetes or prediabetes is still unclear. This study aimed to investigate the predictive value of the SHR for all-cause and cardiovascular mortality in patients with diabetes or prediabetes. Methods This study included 11,160 patients diagnosed with diabetes or prediabetes from the National Health and Nutrition Examination Survey (2005–2018). The study endpoints were all-cause and cardiovascular mortality, and morality data were extracted from the National Death Index (NDI) up to December 31, 2019. Patients were divided into SHR quartiles. Cox proportion hazards regression was applied to determine the prognostic value of SHR. Model 1 was not adjusted for any covariates. Model 2 was adjusted for age, sex, and race. Model 3 was adjusted for age, sex, race, BMI, smoking status, alcohol use, hypertension, CHD, CKD, anemia, and TG. Results During a mean follow-up of 84.9 months, a total of 1538 all-cause deaths and 410 cardiovascular deaths were recorded. Kaplan-Meier survival analysis showed the lowest all-cause mortality incidence was in quartile 3 (P < 0.001). Multivariate Cox regression analyses indicated that, compared to the 1st quartile, the 4th quartile was associated with higher all-cause mortality (model 1: HR = 0.89, 95% CI 0.74–10.7, P = 0.226; model 2: HR = 1.24, 95% CI 1.03-1.49, P = 0.026; model 3: HR = 1.30, 95% CI 1.08–1.57, P = 0.006). The 3rd quartile was associated with lower cardiovascular mortality than quartile 1 (model 1: HR = 0.47, 95% CI 0.32–0.69, P < 0.001; model 2: HR = 0.66, 95% CI 0.45–0.96, P = 0.032; model 3: HR = 0.68, 95% CI 0.46–0.99, P = 0.049). There was a U-shaped association between SHR and all-cause mortality and an L-shaped association between SHR and cardiovascular mortality, with inflection points of SHR for poor prognosis of 0.87 and 0.93, respectively. Conclusion SHR is related to all-cause and cardiovascular mortality in patients with diabetes or prediabetes. SHR may have predictive value in those patients.
first_indexed 2024-03-07T15:21:44Z
format Article
id doaj.art-42d5649a30d746f1909dcca3437d8dc5
institution Directory Open Access Journal
issn 1475-2840
language English
last_indexed 2024-03-07T15:21:44Z
publishDate 2024-02-01
publisher BMC
record_format Article
series Cardiovascular Diabetology
spelling doaj.art-42d5649a30d746f1909dcca3437d8dc52024-03-05T17:36:27ZengBMCCardiovascular Diabetology1475-28402024-02-0123111110.1186/s12933-024-02172-8The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018Lei Ding0Hongda Zhang1Cong Dai2Aikai Zhang3Fengyuan Yu4Lijie Mi5Yingjie Qi6Min Tang7Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical CollegeDepartment of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical CollegeDepartment of Health Policy and Management, School of Public Health, Peking University Health Science CenterDepartment of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical CollegeDepartment of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical CollegeDepartment of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical CollegeDepartment of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical CollegeDepartment of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical CollegeAbstract Background The Stress hyperglycemia ratio (SHR) is a novel marker reflecting the true acute hyperglycemia status and is associated with clinical adverse events. The relationship between SHR and mortality in patients with diabetes or prediabetes is still unclear. This study aimed to investigate the predictive value of the SHR for all-cause and cardiovascular mortality in patients with diabetes or prediabetes. Methods This study included 11,160 patients diagnosed with diabetes or prediabetes from the National Health and Nutrition Examination Survey (2005–2018). The study endpoints were all-cause and cardiovascular mortality, and morality data were extracted from the National Death Index (NDI) up to December 31, 2019. Patients were divided into SHR quartiles. Cox proportion hazards regression was applied to determine the prognostic value of SHR. Model 1 was not adjusted for any covariates. Model 2 was adjusted for age, sex, and race. Model 3 was adjusted for age, sex, race, BMI, smoking status, alcohol use, hypertension, CHD, CKD, anemia, and TG. Results During a mean follow-up of 84.9 months, a total of 1538 all-cause deaths and 410 cardiovascular deaths were recorded. Kaplan-Meier survival analysis showed the lowest all-cause mortality incidence was in quartile 3 (P < 0.001). Multivariate Cox regression analyses indicated that, compared to the 1st quartile, the 4th quartile was associated with higher all-cause mortality (model 1: HR = 0.89, 95% CI 0.74–10.7, P = 0.226; model 2: HR = 1.24, 95% CI 1.03-1.49, P = 0.026; model 3: HR = 1.30, 95% CI 1.08–1.57, P = 0.006). The 3rd quartile was associated with lower cardiovascular mortality than quartile 1 (model 1: HR = 0.47, 95% CI 0.32–0.69, P < 0.001; model 2: HR = 0.66, 95% CI 0.45–0.96, P = 0.032; model 3: HR = 0.68, 95% CI 0.46–0.99, P = 0.049). There was a U-shaped association between SHR and all-cause mortality and an L-shaped association between SHR and cardiovascular mortality, with inflection points of SHR for poor prognosis of 0.87 and 0.93, respectively. Conclusion SHR is related to all-cause and cardiovascular mortality in patients with diabetes or prediabetes. SHR may have predictive value in those patients.https://doi.org/10.1186/s12933-024-02172-8Stress hyperglycemia ratio (SHR)All-cause mortalityCardiovascular mortalityDiabetesPrediabetes
spellingShingle Lei Ding
Hongda Zhang
Cong Dai
Aikai Zhang
Fengyuan Yu
Lijie Mi
Yingjie Qi
Min Tang
The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018
Cardiovascular Diabetology
Stress hyperglycemia ratio (SHR)
All-cause mortality
Cardiovascular mortality
Diabetes
Prediabetes
title The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018
title_full The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018
title_fullStr The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018
title_full_unstemmed The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018
title_short The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018
title_sort prognostic value of the stress hyperglycemia ratio for all cause and cardiovascular mortality in patients with diabetes or prediabetes insights from nhanes 2005 2018
topic Stress hyperglycemia ratio (SHR)
All-cause mortality
Cardiovascular mortality
Diabetes
Prediabetes
url https://doi.org/10.1186/s12933-024-02172-8
work_keys_str_mv AT leiding theprognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018
AT hongdazhang theprognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018
AT congdai theprognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018
AT aikaizhang theprognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018
AT fengyuanyu theprognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018
AT lijiemi theprognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018
AT yingjieqi theprognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018
AT mintang theprognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018
AT leiding prognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018
AT hongdazhang prognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018
AT congdai prognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018
AT aikaizhang prognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018
AT fengyuanyu prognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018
AT lijiemi prognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018
AT yingjieqi prognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018
AT mintang prognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018